Table 4.
Endoscopic ultrasound and contrast enhanced endoscopic ultrasound imaging features of serous pancreatic neoplasia lesions n (%)
| Characteristic | SPN lesions (n = 61) |
| EUS | |
| Anechoic | 2 (3.3) |
| Hypoechoic | 56 (91.8) |
| Isoechoic | 3 (4.9) |
| EUS-CDI vessel detectable | |
| Avascular | 0 |
| Macrovessels detectable | 61 (100) |
| EUS-CDI vascular pattern (n = 61) | |
| Central artery | 26 (42.6) |
| Typical spoke wheel appearance | 15 (24.6) |
| No specifics | 20 (32.8) |
| CE-EUS (n = 54) | |
| Hyperenhancement | 54 (100) |
| Isoenhancement | 0 |
| Hypoenhancement | 0 |
| Final EUS-Diagnosis | |
| “Eyecatcher” | 49 (80.3) |
| Typical SCA | 5 (8.2) |
| Unclear macrocyst | 6 (9.8) |
EUS: Endoscopic ultrasound; EUS-CDI: Endoscopic ultrasound color Doppler Imaging; CE-EUS: Contrast enhanced endoscopic ultrasound; SPN: Serous pancreatic neoplasia; SCA: Serous cystadenoma.